Amgen Net Income 2006-2019 | AMGN

Amgen annual/quarterly net income history and growth rate from 2006 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Amgen net income for the quarter ending June 30, 2019 was $2.179B, a 5.1% decline year-over-year.
  • Amgen net income for the twelve months ending June 30, 2019 was $7.958B, a 236.63% increase year-over-year.
  • Amgen annual net income for 2018 was $8.394B, a 324.15% increase from 2017.
  • Amgen annual net income for 2017 was $1.979B, a 74.37% decline from 2016.
  • Amgen annual net income for 2016 was $7.722B, a 11.28% increase from 2015.
Amgen Annual Net Income
(Millions of US $)
2018 $8,394
2017 $1,979
2016 $7,722
2015 $6,939
2014 $5,158
2013 $5,081
2012 $4,345
2011 $3,683
2010 $4,627
2009 $4,605
2008 $4,052
2007 $3,078
2006 $2,950
2005 $3,674
Amgen Quarterly Net Income
(Millions of US $)
Q2 2019 $2,179
Q1 2019 $1,992
Q4 2018 $1,928
Q3 2018 $1,859
Q2 2018 $2,296
Q1 2018 $2,311
Q4 2017 $-4,264
Q3 2017 $2,021
Q2 2017 $2,151
Q1 2017 $2,071
Q4 2016 $1,935
Q3 2016 $2,017
Q2 2016 $1,870
Q1 2016 $1,900
Q4 2015 $1,800
Q3 2015 $1,863
Q2 2015 $1,653
Q1 2015 $1,623
Q4 2014 $1,294
Q3 2014 $1,244
Q2 2014 $1,547
Q1 2014 $1,073
Q4 2013 $1,021
Q3 2013 $1,368
Q2 2013 $1,258
Q1 2013 $1,434
Q4 2012 $788
Q3 2012 $1,107
Q2 2012 $1,266
Q1 2012 $1,184
Q4 2011 $934
Q3 2011 $454
Q2 2011 $1,170
Q1 2011 $1,125
Q4 2010 $1,022
Q3 2010 $1,236
Q2 2010 $1,202
Q1 2010 $1,167
Q4 2009 $931
Q3 2009 $1,386
Q2 2009 $1,269
Q1 2009 $1,019
Q4 2008 $925
Q3 2008 $1,121
Q2 2008 $906
Q1 2008 $1,100
Q4 2007 $747
Q3 2007 $201
Q2 2007 $1,019
Q1 2007 $1,111
Q4 2006 $833
Q3 2006 $1,102
Q2 2006 $14
Q1 2006 $1,001
Q4 2005 $824
Q3 2005 $967
Q2 2005 $1,029
Q1 2005 $854
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $121.841B $23.747B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
Gilead Sciences (GILD) United States $80.344B 9.87
Celgene (CELG) United States $67.515B 10.44
Vertex Pharmaceuticals (VRTX) United States $47.223B 51.03
Biogen (BIIB) United States $42.659B 7.58
Illumina (ILMN) United States $41.844B 49.16
CSL (CSLLY) Australia $35.681B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.513B 14.76
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.986B 13.17
Incyte (INCY) United States $18.087B 53.23
Exact Sciences (EXAS) United States $15.468B 0.00
SINO PHARMACEUT (SBMFF) China $15.039B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.731B 0.00
Seattle Genetics (SGEN) United States $12.716B 0.00
Genmab (GNMSF) Denmark $12.462B 63.35
Bio-Rad Laboratories (BIO.B) United States $9.886B 52.99
Guardant Health (GH) United States $9.507B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.135B 0.00
Galapagos (GLPG) Belgium $8.548B 0.00
QIAGEN (QGEN) Netherlands $7.706B 25.31
Sarepta Therapeutics (SRPT) United States $7.588B 0.00
Bio-Techne Corp (TECH) United States $7.294B 50.42
BeiGene (BGNE) Cayman Islands $6.892B 0.00
Bluebird Bio (BLUE) United States $6.718B 0.00
Exelixis (EXEL) United States $6.591B 17.13
Amarin (AMRN) Ireland $5.512B 0.00
Horizon Pharma Public (HZNP) Ireland $5.144B 13.08
Ascendis Pharma (ASND) Denmark $4.867B 0.00
Repligen (RGEN) United States $4.749B 92.15
Moderna (MRNA) United States $4.672B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.412B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.231B 0.00
MorphoSys AG (MOR) Germany $3.897B 0.00
China Biologic Products (CBPO) China $3.897B 24.32
Spark Therapeutics (ONCE) United States $3.881B 0.00
Blueprint Medicines (BPMC) United States $3.859B 0.00
Mirati Therapeutics (MRTX) United States $3.479B 0.00
Alkermes (ALKS) Ireland $3.421B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.343B 0.00
Arena Pharmaceuticals (ARNA) United States $2.838B 6.10
Genomic Health (GHDX) United States $2.754B 51.65
Immunomedics (IMMU) United States $2.695B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.652B 0.00
NeoGenomics (NEO) United States $2.646B 141.56
Amicus Therapeutics (FOLD) United States $2.615B 0.00
Medicines (MDCO) United States $2.605B 0.00
MyoKardia (MYOK) United States $2.547B 0.00
Acceleron Pharma (XLRN) United States $2.411B 0.00
Halozyme Therapeutics (HALO) United States $2.410B 0.00
Reata Pharmaceuticals (RETA) United States $2.321B 0.00
Emergent Biosolutions (EBS) United States $2.214B 33.26
Intercept Pharmaceuticals (ICPT) United States $2.153B 0.00
UniQure (QURE) Netherlands $2.134B 0.00
Akcea Therapeutics (AKCA) United States $2.073B 0.00
Cambrex (CBM) United States $1.991B 25.17
Zai Lab (ZLAB) China $1.976B 0.00
Ligand Pharmaceuticals (LGND) United States $1.820B 23.01
Myriad Genetics (MYGN) United States $1.809B 18.98
Denali Therapeutics (DNLI) United States $1.804B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.636B 0.00
Insmed (INSM) United States $1.496B 0.00
Coherus BioSciences (CHRS) United States $1.400B 0.00
RA PHARMCTL INC (RARX) United States $1.375B 0.00
REGENXBIO (RGNX) United States $1.336B 0.00
Sangamo Therapeutics (SGMO) United States $1.331B 0.00
Editas Medicine (EDIT) United States $1.267B 0.00
Fate Therapeutics (FATE) United States $1.231B 0.00
Epizyme (EPZM) United States $1.230B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.228B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.210B 0.00
Athenex (ATNX) United States $1.205B 0.00
Innoviva (INVA) United States $1.165B 3.36
AnaptysBio (ANAB) United States $1.141B 0.00
Alector (ALEC) United States $1.101B 0.00
Zymeworks (ZYME) Canada $1.025B 0.00
Twist Bioscience (TWST) United States $1.000B 0.00
Cara Therapeutics (CARA) United States $0.943B 0.00
Principia Biopharma (PRNB) United States $0.930B 485.13
Dicerna Pharmaceuticals (DRNA) United States $0.911B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.853B 0.00
Intellia Therapeutics (NTLA) United States $0.828B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.821B 0.00
ANI Pharmaceuticals (ANIP) United States $0.815B 13.61
Arvinas (ARVN) United States $0.809B 0.00
Cytokineticsorporated (CYTK) United States $0.809B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.806B 29.08
Alder BioPharmaceuticals (ALDR) United States $0.781B 0.00
Anika Therapeutics (ANIK) United States $0.767B 27.16
Codexis (CDXS) United States $0.759B 0.00
Pharming Group (PHGUF) Netherlands $0.759B 0.00
Vericel (VCEL) United States $0.748B 0.00
Adverum Biotechnologies (ADVM) United States $0.748B 0.00
Retrophin (RTRX) United States $0.734B 0.00
WAVE Life Sciences (WVE) Singapore $0.730B 0.00
Zealand Pharma (ZEAL) Denmark $0.671B 7.79
Zealand Pharma (ZLDPF) Denmark $0.664B 0.00
Stemline Therapeutics (STML) United States $0.660B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.643B 0.00
MiMedx (MDXG) United States $0.608B 0.00
Heska (HSKA) United States $0.578B 74.92
DBV Technologies S.A (DBVT) France $0.564B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.517B 0.00
Cellectis S.A (CLLS) France $0.517B 0.00
Precision BioSciences (DTIL) United States $0.500B 0.00
Intra-Cellular Therapies (ITCI) United States $0.494B 0.00
Revance Therapeutics (RVNC) United States $0.493B 0.00
PHARMA MAR SA (PHMMF) Spain $0.479B 0.00
Syros Pharmaceuticals (SYRS) United States $0.466B 0.00
Mesoblast (MESO) Australia $0.464B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.446B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.434B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.432B 0.00
CytomX Therapeutics (CTMX) United States $0.420B 0.00
Puma Biotechnology (PBYI) United States $0.419B 0.00
Merus (MRUS) Netherlands $0.412B 0.00
BioDelivery Sciences (BDSI) United States $0.396B 0.00
Agenus (AGEN) United States $0.393B 0.00
AC Immune SA (ACIU) Switzerland $0.382B 28.25
Avid Bioservices (CDMO) United States $0.371B 0.00
Gritstone Oncology (GRTS) United States $0.368B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.364B 0.00
Kadmon Holdings (KDMN) United States $0.344B 0.00
Scholar Rock Holding (SRRK) United States $0.334B 0.00
Clovis Oncology (CLVS) United States $0.330B 0.00
Arcus Biosciences (RCUS) United States $0.326B 0.00
Biofrontera AG (BFRA) Germany $0.323B 0.00
Albireo Pharma (ALBO) United States $0.322B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
Theratechnologies (THERF) Canada $0.318B 0.00
Protagonist Therapeutics (PTGX) United States $0.309B 0.00
Prothena (PRTA) Ireland $0.307B 0.00
Cel-Sci (CVM) United States $0.299B 0.00
Sorrento Therapeutics (SRNE) United States $0.299B 0.00
PDL BioPharma (PDLI) United States $0.294B 7.56
Kindred Biosciences (KIN) United States $0.288B 0.00
Dynavax Technologies (DVAX) United States $0.285B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.275B 0.00
Geron (GERN) United States $0.260B 0.00
Senesco Technologies (ELOX) United States $0.253B 0.00
ADMA Biologics Inc (ADMA) United States $0.241B 0.00
PHASEBIO PHARMA (PHAS) United States $0.241B 0.00
Seres Therapeutics (MCRB) United States $0.239B 0.00
Inovio Pharmaceuticals (INO) United States $0.238B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.237B 0.00
Cellular Biomedicine (CBMG) United States $0.236B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.233B 0.00
Prometic Life Sciences (PFSCF) Canada $0.230B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.229B 0.00
ChromaDex (CDXC) United States $0.225B 0.00
Pfenex (PFNX) United States $0.223B 0.00
MannKind (MNKD) United States $0.217B 0.00
Kamada (KMDA) Israel $0.217B 8.28
Athersys (ATHX) United States $0.215B 0.00
Five Prime Therapeutics (FPRX) United States $0.213B 0.00
Compugen (CGEN) Israel $0.201B 0.00
CorMedix Inc (CRMD) United States $0.198B 0.00
Palatin Technologies (PTN) United States $0.197B 0.00
Sutro Biopharma (STRO) United States $0.195B 0.00
Spero Therapeutics (SPRO) United States $0.188B 0.00
Cue Biopharma (CUE) United States $0.181B 0.00
Affimed (AFMD) Germany $0.178B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.170B 0.00
Dyadic (DYAI) United States $0.168B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Cerecor (CERC) United States $0.164B 0.00
POXEL SA FRANCE (PXXLF) $0.163B 0.00
Emmaus Life Sciences (EMMA) United States $0.160B 0.00
Novavax (NVAX) United States $0.160B 0.00
Arsanis (XFOR) United States $0.159B 0.00
Acorda Therapeutics (ACOR) United States $0.155B 0.00
OSMOTICA PHARM (OSMT) United States $0.155B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.153B 0.00
BioTime (LCTX) United States $0.151B 10.10
Alcobra (ARCT) United States $0.151B 0.00
XOMA (XOMA) United States $0.150B 0.00
Enzo Biochem (ENZ) United States $0.149B 0.00
Nicox SA (NICXF) France $0.147B 0.00
Strongbridge Biopharma (SBBP) United States $0.143B 5.87
Lexicon Pharmaceuticals (LXRX) United States $0.140B 0.00
Adocia (ADOCY) France $0.140B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.137B 0.00
Mersana Therapeutics (MRSN) United States $0.130B 0.00
Windtree Therapeutics (WINT) United States $0.125B 0.00
NantKwest (NK) United States $0.125B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.121B 0.00
Celyad SA (CYAD) Belgium $0.120B 0.00
Fortress Biotech (FBIO) United States $0.120B 0.00
SESEN BIO, INC (SESN) United States $0.118B 0.00
Northwest Biotherapeutics (NWBO) United States $0.115B 0.00
TOCAGEN INC (TOCA) United States $0.113B 0.00
Synlogic (SYBX) United States $0.111B 0.00
Aduro Biotech (ADRO) United States $0.109B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.109B 0.00
Abeona Therapeutics (ABEO) United States $0.108B 0.00
Checkpoint Therapeutics (CKPT) United States $0.107B 0.00
Aptinyx (APTX) United States $0.104B 0.00
Liquidia Technologies (LQDA) United States $0.102B 0.00
Menlo Therapeutics (MNLO) United States $0.099B 0.00
OvaScience (MLND) United States $0.096B 0.00
Verastem (VSTM) United States $0.096B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.093B 0.00
Catalyst Biosciences (CBIO) United States $0.088B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.086B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
Trevena (TRVN) United States $0.083B 0.00
Arbutus Biopharma (ABUS) Canada $0.083B 0.00
Selecta Biosciences (SELB) United States $0.081B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.077B 0.00
Vaccinex (VCNX) United States $0.077B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.074B 0.00
VTv Therapeutics (VTVT) United States $0.073B 0.00
Antibe Therapeutics (ATBPF) Canada $0.072B 0.00
Curis (CRIS) United States $0.070B 0.00
Orgenesis (ORGS) United States $0.070B 0.00
AquaBounty Technologies (AQB) United States $0.070B 0.00
ARAVIVE, INC (ARAV) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.065B 0.00
Idera Pharmaceuticals (IDRA) United States $0.065B 0.00
Unum Therapeutics (UMRX) United States $0.063B 0.00
VBI Vaccines (VBIV) United States $0.062B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Prima BioMed (IMMP) Australia $0.057B 0.00
AIT Therapeutics (XAIR) United States $0.055B 0.00
Applied Genetic Technologies (AGTC) United States $0.054B 29.70
China Health Industries Holdings (CHHE) China $0.054B 20.47
Oncobiologics (OTLK) United States $0.054B 0.00
Ophthotech (ISEE) United States $0.046B 0.00
Clearside Biomedical (CLSD) United States $0.044B 0.00
Signal Genetics (MGEN) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
VIVUS (VVUS) United States $0.042B 0.00
Evogene (EVGN) Israel $0.041B 0.00
Celsion (CLSN) United States $0.041B 0.00
Apricus Biosciences (SEEL) United States $0.038B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Protalix BioTherapeutics (PLX) Israel $0.037B 0.00
Aptevo Therapeutics (APVO) United States $0.035B 0.00
AEterna Zentaris (AEZS) United States $0.035B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Proteostasis Therapeutics (PTI) United States $0.034B 0.00
BIOCARDIA INC (BCDA) United States $0.033B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.032B 0.00
Entera Bio (ENTX) Israel $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.032B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
VistaGen Therapeutics (VTGN) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.023B 0.00
Soligenix (SNGX) United States $0.022B 0.00
Bionano Genomics (BNGO) United States $0.021B 0.00
Vical (VICL) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 6.33
IBio (IBIO) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
TRACON Pharmaceuticals (TCON) United States $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
Novelion Therapeutics (NVLN) Canada $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
AmpliPhi Biosciences (ARMP) United States $0.011B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Hemispherx BioPharma (HEB) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) Canada $0.004B 0.00
BioPharmX (BPMX) United States $0.003B 0.00
Neuralstem (CUR) United States $0.002B 0.00